8EHQ-10-17847A TSCA 8(e) Notice

First Page		Document Content
Date: 2012-07-24 13:53:51 Routes of administration Dosage forms Diols Excipients Propylene glycol Injection Intraperitoneal injection Dipropylene glycol Pharmacology Pharmaceutical sciences Pharmacy		8EHQ-10-17847A TSCA 8(e) Notice Add to Reading List Source URL: www.epa.gov Download Document from Source Website File Size: 63,23 KB Share Document on Facebook

	Pharmaceutical Excipients Chelating Agents  Calcium Disodium EDTA DocID: 1tnbI - View Document
	Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 DocID: 1rrGr - View Document
	Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 DocID: 1rrm1 - View Document
	Symptoms of abdominal pain, gas, bloating, flatulence, burping, constipation and/or diarrhea are commonly present in various gastrointestinal disorders but are hard to treat and minimize symptoms. Often these symptoms ar DocID: 1rlg8 - View Document
	Effect of Excipients on the Phase Transformation of Carbamazepine Anhydrous to its Hydrated Form Heather Clarke, Christi Hoffman, Sangati Gandhi, Mark Cappucci, Jeffery Williamson, Paul Skultety Xcelience, 5415 W. Laurel DocID: 1rh5V - View Document